In this task, you're given a paragraph from the research paper and your task is to generate a suitable title for the research paper based on the given paper. Under 100 words is a good title length.

Input: Consider Input: This study investigates property securities bubbles and crashes by using a dynamic mathematical methodology developed from the previous research (Watanabe et al. 2007a, b [31,32]). The improved model is used to detect the bubble and crash periods in five international countries/cities (namely, . By this model definition, we are able to detect the beginning of each bubble period even before it bursts. Meanwhile, the empirical results show that most of property securities markets experienced bubble periods between 2003 and 2007, and crashes happened in Apr 2008 triggered by the Subprime Mortgage Crisis of US. In contrast, Japan suffered the shortest bubble period and no evidence has documented the existence of crash there.

Output: Physica A A dynamic mathematical test of international property securities bubbles and crashes


Input: Consider Input: Over the past several decades, significant advances have been made in identifying factors that contribute to the pathogenesis of multiple sclerosis (MS) and have culminated in the approval of some effective therapeutic strategies for disease intervention. However, the mechanisms by which environmental factors, such as infection, contribute to the pathogenesis and/or symptom exacerbation remain to be fully elucidated. Relapse frequency in MS patients contributes to neurological impairment and, in the initial phases of disease, serves as a predictor of poor disease prognosis. The purpose of this review is to examine the evidence that supports a role for peripheral infection in modulating the natural history of this disease. Evidence supporting a role for infection in promoting exacerbation in animal models of MS is also reviewed. Finally, a few mechanisms by which infection may exacerbate symptoms of MS and other neurological diseases are discussed. Those who comprise the majority of MS patients acquire approximately two upper-respiratory infections per year; furthermore, this type of infection doubles the risk for MS relapse, underscoring the contribution of this relationship as being potentially important and particularly detrimental.

Output: infection as an environmental trigger of multiple sclerosis disease exacerbation


Input: Consider Input: This study was performed to investigate the mechanism of action of ursolic acid in terms of anti-Toxoplasma gondii effects, including immunomodulatory effects. We evaluated the anti-T. gondii effects of ursolic acid, and analyzed the production of nitric oxide (NO), reactive oxygen species (ROS), and cytokines through co-cultured immune cells, as well as the expression of intracellular organelles of T. gondii. The subcellular organelles and granules of T. gondii, particularly rhoptry protein 18, microneme protein 8, and inner membrane complex sub-compartment protein 3, were markedly decreased when T. gondii was treated with ursolic acid, and their expressions were effectively inhibited. Furthermore, ursolic acid effectively increased the production of NO, ROS, interleukin (IL)-10, IL-12, granulocyte macrophage colony stimulating factor (GM-CSF), and interferon-β, while reducing the expression of IL-1β, IL-6, tumor necrosis factor alpha (TNF-α), and transforming growth factor beta 1 (TGF-β1) in T. gondii-infected immune cells. These results demonstrate that ursolic acid not only causes anti-T. gondii activity/action by effectively inhibiting the survival of T. gondii and the subcellular organelles of T. gondii, but also induces specific immunomodulatory effects in T. gondii-infected immune cells. Therefore, this study indicates that ursolic acid can be effectively utilized as a potential candidate agent for developing novel anti-toxoplasmosis drugs, and has immunomodulatory activity. different sub-proteins such as IMC sub-compartment proteins 1, 2, and 3 [2] [3] [4] . The protein kinases of T. gondii have been known to play key roles for modulating the motility, invasion, replication, egress, and survival within the host [5] . It was reported that T. gondii is divided through a unique form of cell division such as endodyogeny, and its chromosomal passenger complex is essential for the organization of a functional mitotic spindle [6] . Furthermore, T. gondii not only forms a parasitophorous vacuole membrane (PVM) after invasion into host cells, but also proliferates and grows into a PVM [7-9]. For decades, several compounds through many researchers and groups were developed as drugs for treating toxoplasmosis, and are usefully used in clinics. However, existing drugs are widely vulnerable to drug-resistance in clinics globally. To overcome pharmacological barriers to these challenges, the efforts for treating infectious diseases have been attempted in various fields, and it has been reported that various extracts/compounds derived from medicinal plants and new synthetic compounds have anti-T. gondii effects in the in vitro and pre-clinic stages [10] [11] [12] [13] [14] [15] . Until recently, various compounds derived from plants have showed a leading role and ability as a source of specialized metabolites with medical effects as well as pharmacological activities. In addition, it was reported that various extracts/compounds derived from plants and synthetic compounds could be used in the medical field as useful resources for treating acute or chronic infectious diseases caused by schistosomiasis, leishmania, malaria, or tuberculosis, as well as viral diseases including middle east respiratory syndrome (MERS) or Zika fever and avian influenza [16] [17] [18] [19] [20] [21] [22] [23] . However, effective next-generation drugs for treating toxoplasmosis have not yet been developed, and the difficulty of drug development against zoonosis is still causing a public health crisis globally. In this context, various studies on the development or discovery of effective drugs and novel candidates against parasitic zoonosis are urgently required. In this regard, ursolic acid is a bioactive compound derived from medicinal plants, and is also known to have selective bioactive properties such as anti-inflammatory [24-27] and anticancer effects [28] [29] [30] [31] . It also effectively induces various activities, including antimicrobial [32-34] and anti-parasitic effects [35, 36] . Until recently, although studies and compounds regarding anti-T. gondii activity have been reported globally [37] [38] [39] [40] [41] [42] [43] , the mechanism of action of ursolic acid on the inhibitory effect of T. gondii and the immunomodulatory activity was not reported yet. From this perspective, this study was performed to evaluate the mechanism of action and the immunomodulatory activity of ursolic acid in terms of anti-T. gondii effects and activity, and to confirm the potential as a potent candidate drug for developing novel anti-toxoplasmosis agents. Results T. gondii has a specific network structure and systems, including various intracellular organelles such as the mitochondrion, apicoplast, dense granule, and rhoptry (Figure 1) , which induces serious zoonotic diseases such as toxoplasmosis, particularly in humans, while causing infection in various vertebrates. Before evaluating the mechanism of action of ursolic acid against T. gondii, we measured the inhibitory effect of ursolic acid (UA) against the survival of T. gondii and normal lung cells infected with T. gondii through an MTT assay as described previously [9] , which showed significant results and reproducibility. When T. gondii was treated with UA (12.5-400 µg/mL) for 24 h, the viability was effectively inhibited, and the parasitic survival rate was measured as less than 30% at 200 µg/mL. UA strongly decreased the viability of T. gondii compared with sulfadiazine (SF), which demonstrates that UA caused anti-T. gondii effect or activity against T. gondi (data not shown). In particular, the lung cells infected with T. gondii were markedly inhibited in a dose-dependent manner after treatment with ursolic acid (12.5-200 µg/mL) when compared with the untreated infection cells and the T. gondii-infected cells treated with SF ( Figure 2) . Furthermore, it was clearly shown that there were significant differences between the untreated T. gondii-group and the experimental groups. In these aspects, it was demonstrated that UA effectively induced the selective anti-parasitic effect/action compared to the SF-treated group and the untreated group through a direct inhibitory effect on the Pathogens 2019, 8, 61 3 of 18 viability of T. gondii. This shows that UA has the potential to be utilized as an anti-T. gondii candidate agent and/or a synergic compound with the existing drugs for developing novel anti-toxoplasmosis agents. Therefore, these results indicate that UA strongly inhibits or blocks the survival of T. gondii by effectively inducing anti-T. gondii activity through the selective inhibitory activity and/or action against the viability of T. gondii.


Output: The Mechanism of Action of Ursolic Acid as a Potential Anti-Toxoplasmosis Agent, and Its Immunomodulatory Effects